10-Q: OneMedNet Reports Q1 2025 Results, Revenue Declines Amid Strategic Shift

OneMedNet Corporation's Q1 2025 revenue decreased by 45% year-over-year as the company transitions away from its BEAM platform and focuses on iRWD sales.

Summary

• OneMedNet Corporation reported a net loss of $1.9 million for the three months ended March 31, 2025.
• Revenue decreased by 45% to $137,000 compared to $248,000 in the same period last year.
• Subscription revenue declined by 71% due to the planned discontinuation of the BEAM platform.
• Web imaging revenue increased by 68% due to a focus on iRWD sales.
• The company's cash and Bitcoin balance as of March 31, 2025, was $0.1 million and $0.8 million, respectively.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company plans to raise additional working capital through equity or debt offerings.
• Cost of revenue increased as a percentage of revenue due to the BEAM platform transition and higher iRWD data and personnel costs.
• The company is strategically investing in Bitcoin, with holdings valued at $793,000 as of March 31, 2025.
• The company entered into securities purchase agreements with related party investors to issue 1,904,762 shares of common stock at $0.42 per share, raising approximately $0.8 million.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with declining revenue, net losses, and doubts about the company's ability to continue as a going concern. While there are some positive aspects, such as the increase in web imaging revenue and strategic investment in Bitcoin, the overall sentiment is negative due to the significant financial challenges.

Positives

• Web imaging revenue increased by 68% due to a focus on iRWD sales.
• The company is strategically investing in Bitcoin, with holdings valued at $793,000 as of March 31, 2025.
• The company entered into securities purchase agreements with related party investors to issue 1,904,762 shares of common stock at $0.42 per share, raising approximately $0.8 million.

Negatives

• Q1 2025 revenue decreased by 45% to $137,000 compared to $248,000 in Q1 2024.
• Subscription revenue (BEAM) declined 71% due to the planned discontinuation of the platform.
• Net loss for Q1 2025 was $1.9 million.
• The company's cash and Bitcoin balance as of March 31, 2025, was $0.1 million and $0.8 million, respectively.
• There is substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's cash and Bitcoin balance is not adequate to fund operations for the next twelve months.
• The company may not be able to secure financing in a timely manner or on favorable terms.
• The company's continuation as a going concern is dependent upon its ability to continue receiving working capital cash payments and generating cash flow from operations.
• The company is subject to risks common to companies in the markets it serves, including global economic and financial market conditions, fluctuations in customer demand, and acceptance of new products.
• The company has invested in Bitcoin, which is a crypto asset with volatile prices and regulatory uncertainty.
• The company's failure to file a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock issued under the SEPA is deemed an event of default under the SEPA.

Future Outlook

The company intends to raise cash for operations through debt and equity offerings and hopes to attain profitable operations to fulfill its operating and capital requirements for at least 12 months from the date of the issuance of the condensed consolidated financial statements.

Industry Context

The company operates in the healthcare software industry, which is characterized by rapid technological advancements and increasing demand for digital medical image management solutions. The shift from BEAM to iRWD reflects a strategic decision to focus on higher-value, regulatory-grade data solutions for the life science market.

Comparison to Industry Standards

• It is difficult to compare OneMedNet's results directly to industry standards due to its unique business model and size.
• Larger companies in the medical imaging and data analytics space, such as Change Healthcare (now part of Optum), have significantly higher revenue and resources.
• Smaller, more specialized companies like Arterys or Zebra Medical Vision focus on specific AI-powered solutions within medical imaging.
• OneMedNet's focus on iRWD and federated provider networks positions it uniquely, but also requires significant investment in data security and regulatory compliance, similar to companies like Datavant in the healthcare data exchange space.

Related Party Transactions

• The company received gross proceeds of $1.6 million in connection with shareholder loans with a related party investor which are convertible into 2,123,312 shares of Common Stock at a conversion price of $0.7535 per share.
• Data Knights issued and sold PIPE Notes in connection with the Business Combination, of which $1.0 million was with related party investors.
• In connection with the issuance of the PIPE Notes, the Company also issued a total of 95,744 shares of PIPE Warrants, of which 63,829 shares were issued to the same related party investors.
• The company also issued $0.7 million in non-convertible shareholder loans with related party investors during 2023 and 2024.
• Between April and May 2025, the Company entered into securities purchase agreements with two related party investors, pursuant to which the Company agreed to issue and sell 1,904,762 shares of its Common Stock at a price of $ 0.42 per share.

Stakeholder Impact

• Shareholders may experience dilution if the company issues equity securities to raise additional funds.
• Employees may be affected by the company's financial challenges and potential restructuring.
• Customers may be impacted by the company's strategic shift and discontinuation of the BEAM platform.
• Creditors face increased risk due to the company's financial instability and potential inability to repay debts.

Next Steps

• The company intends to raise cash for operations through debt and equity offerings.
• The company needs to address the material weaknesses in its internal controls over financial reporting.
• The company needs to file a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock issued under the SEPA.

Key Dates

Keywords

OneMedNet, iRWD, BEAM, revenue, Bitcoin, financial results, Q1 2025, going concern, PIPE Notes, Yorkville Note, SEPA, warrants, common stock, healthcare software, medical imaging